Ann: Ryoncil Pricing Set and Available This Quarter, page-451

  1. 6,957 Posts.
    lightbulb Created with Sketch. 2796

    Obligating Health Insurers to Cover an FDA-Approved Treatment Before Pricing Is Negotiated

    The ability to force an insurer to cover a newly FDA-approved treatment before pricing is set depends on the type of insurance and applicable laws. Here’s a breakdown by insurance category:

    1. Private Health Insurance (Employer-Sponsored & Marketplace Plans)

    Possible, but challenging

    • Private insurers typically determine coverage through medical policies and formularies that assess clinical effectiveness and cost.
    • Even if a treatment is FDA-approved, insurers may wait for pricing negotiations before deciding coverage.
    • State laws may require quicker coverage for FDA-approved treatments, especially in cancer or rare disease cases.

    Options for Patients & Providers

    Medical Exception or Appeal – A doctor can argue medical necessity to request early coverage.
    State-Level Insurance Commissioner Complaint – If state law mandates coverage, regulators can intervene.
    Employer Pressure – If an employer sponsors the plan, they may negotiate coverage directly.

    2. Medicare (Traditional & Advantage Plans)

    Limited, but possible

    • Medicare Part B (doctor-administered drugs) & Part D (prescription drugs) follow CMS reimbursement determinations, which take time after FDA approval.
    • National Coverage Determinations (NCDs) and Local Coverage Determinations (LCDs) influence whether Medicare pays early.

    Options for Patients & Providers

    Compassionate Use / Expanded Access Programs – Some drugs may be available via patient assistance programs.
    Administrative Appeals – If a doctor proves medical necessity, Medicare may approve individual cases.
    Congressional or Legal Pressure – In high-profile cases, policymakers may push for faster Medicare coverage.

    3. Medicaid (State-Run Programs)

    More likely due to federal mandates

    • Medicaid must cover FDA-approved drugs that participate in the Medicaid Drug Rebate Program (MDRP).
    • However, states can implement prior authorization requirements before formal pricing is set.

    Options for Patients & Providers

    Medicaid Fair Hearing Request – Patients can challenge denials through a state appeals process.
    Legal Challenges – In cases where a state Medicaid program delays access, legal action may force coverage.

    4. ACA Plans & Essential Health Benefits

    Depends on state mandates & plan policies

    • ACA marketplace plans must cover essential health benefits, but they have discretion over which new treatments to include.
    • Some states require insurers to cover new FDA-approved treatments faster than federal rules dictate.

    Options for Patients & Providers

    State Insurance Commissioner Complaint – If state law supports coverage, regulators can intervene.
    Expedited Review Requests – Insurers may approve case-by-case exceptions.

    Bottom Line

    It is possible to push an insurer to cover an FDA-approved treatment before pricing is finalized, but it depends on the type of insurance, applicable laws, and medical necessity arguments.


 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.65
Change
0.030(1.85%)
Mkt cap ! $2.108B
Open High Low Value Volume
$1.64 $1.67 $1.63 $4.884M 2.962M

Buyers (Bids)

No. Vol. Price($)
3 10583 $1.65
 

Sellers (Offers)

Price($) Vol. No.
$1.66 16415 4
View Market Depth
Last trade - 16.12pm 27/06/2025 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.